Literature DB >> 21285451

Evaluation of 18FDG PET-CT in the diagnosis of endometriosis: a prospective study.

Maxime Fastrez1, C Nogarède, M Tondeur, N Sirtaine, S Rozenberg.   

Abstract

BACKGROUND: Noninvasive techniques have poor sensitivity and specificity in diagnosing endometriosis, which is often associated with an inflammatory process. In several benign diseases, measurement of hypermetabolism using fluorodeoxyglucose (18F 18FDG) reflects the degree of inflammation and aggressiveness of the disease. This prospective study evaluated the value of (18)FDG positron emission tomography (PET)-computed tomography (CT) in assessing the presence of endometriosis.
METHODS: Ten consecutive patients suspected with endometriosis were prospectively included in this study. A preoperative 18FDG PET-CT was performed in all the patients during the follicular phase of their cycle, which preceded laparoscopic surgery. Surgical endometriosis staging and histopathological analysis of removed tissue were confronted with the results from 18FDG PET-CT.
RESULTS: Of the 10 patients, 9 had endometriosis confirmed by laparoscopy; 6 had advanced stage of the disease and 5 had histologically proven lesions. Nevertheless, none of the patients had 18FDG-demonstrated hypermetabolism at PET-CT.
CONCLUSIONS: In this preliminary series, we did not observe hypermetabolic activity in relation to endometriosis using 18FDG PET-CT. This study's most important limitation is the use of 18FDG as an isotopic tracer, which is not specific to endometrial tissue.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21285451     DOI: 10.1177/1933719110392060

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  7 in total

Review 1.  Imaging modalities for the non-invasive diagnosis of endometriosis.

Authors:  Vicki Nisenblat; Patrick M M Bossuyt; Cindy Farquhar; Neil Johnson; M Louise Hull
Journal:  Cochrane Database Syst Rev       Date:  2016-02-26

2.  Renal endometriosis mimicking complicated cysts of kidney: report of two cases.

Authors:  D Giambelluca; D Albano; E Giambelluca; A Bruno; F Panzuto; A Agrusa; G Di Buono; F Cannizzaro; Cesare Gagliardo; M Midiri; R Lagalla; G Salvaggio
Journal:  G Chir       Date:  2017 Sep-Oct

3.  Retroperitoneal Endometriosis: A Possible Cause of False Positive Finding at (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.

Authors:  Anna Margherita Maffione; Riccardo Panzavolta; Laura Camilla Lisato; Maria Ballotta; Mariangela Zanforlini D'Isanto; Domenico Rubello
Journal:  World J Nucl Med       Date:  2015 May-Aug

4.  A case report of bladder and intestinal endometriosis, and the relationship between sex hormone receptor expression and PIK3CA mutation analysis.

Authors:  Akiko Kanto; Yasushi Kotani; Kosuke Murakami; Chiho Miyagawa; Hidekatsu Nakai; Noriomi Matsumura
Journal:  BMC Womens Health       Date:  2021-03-21       Impact factor: 2.809

5.  (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-positive lymph node endometriosis masquerading as lymph node metastasis of a malignant tumor.

Authors:  Makoto Akiyama; Izumi Suganuma; Taisuke Mori; Izumi Kusuki; Haruo Kuroboshi; Fumitake Ito; Hiroshi Matsushima; Morio Sawada; Jo Kitawaki
Journal:  Case Rep Obstet Gynecol       Date:  2014-08-10

6.  Pulmonary cavitations with increased 18F-FDG uptake revealing a thoracic endometriosis: A case report.

Authors:  Pauline Mulette; Amaury Jacquet; Anne Durlach; Dimitri Papathanassiou; Paul Lalire; Olivier Graesslin; Gonzague Delepine; Sandra Dury; Valérian Dormoy; Jeanne-Marie Perotin; François Lebargy; Gaëtan Deslée; Claire Launois
Journal:  Medicine (Baltimore)       Date:  2021-10-22       Impact factor: 1.817

7.  Interference of Known or Suspected Endometriosis in Reporting FDG PET/CT Performed in Another Indication.

Authors:  Sona Balogova; Emile Daraï; Lucia Noskovicova; Ludovit Lukac; Jean-Noël Talbot; Françoise Montravers
Journal:  Clin Nucl Med       Date:  2022-04-01       Impact factor: 7.794

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.